FDA approves Roche’s Susvimo for neovascular or “wet” age-related macular degeneration (nAMD)
Susvimo, previously called Port Delivery System with ranibizumab, is the first nAMD treatment in 15 years to provide an…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.